14848

    532878

    ALPA

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ALPA LABORATORIES LTD Share Price Today

    ALPA LABORATORIES LTD is currently trading at ₹67.22, up by ₹0.38 from the previous close. The stock touched an intraday high of ₹68.25 and a low of ₹66.15 during the latest trading session. Over the past one year, ALPA LABORATORIES LTD has delivered a loss of 33.82%, while the stock has declined 1.05% in the last one month.

    ALPA LABORATORIES LTD performance

    Today’s low Today’s high
    ₹ 66.15 ₹ 68.25
    ₹ 66.66
    52 week low 52 week high
    ₹ 46.10 ₹ 103.83
    ₹ 66.66
    Open Price ₹ 67.55
    Prev. Close ₹ 66.84
    Volume (Shares) 13453.00
    Total traded value ₹ 8.96
    Upper Circuit ₹ 80.20
    Lower Circuit ₹ 53.48
    info

    Investment Returns

    Over 1 Month -1.05% Over 3 Months 0.99% Over 6 Months -1.83% Over 1 Year -33.82%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ALPA LABORATORIES LTD fundamentals


    • Market cap (Cr) 140.30
    • P/E Ratio (TTM) 9.29
    • Beta 1.04
    • Book Value / share 93.42
    • Return on equity 11.45%
    • EPS (TTM) 7.11
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.36
    info icon alternate text
    • Market cap (Cr) 140.30
    • P/E Ratio (TTM) 9.29
    • Beta 0.89
    • Book Value / share 93.42
    • Return on equity 11.45%
    • EPS (TTM) 7.11
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.36
    info icon alternate text

    ALPA LABORATORIES LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 31.40
    Operating Expense 28.17
    Net Profit 1.36
    Net Profit Margin (%) 4.33
    Earnings Per Share (EPS) 0.64
    EBITDA 3.42
    Effective Tax Rate (%) 55.59
    Particulars DEC 2025 (Values in Cr)
    Revenue 29.67
    Operating Expense 28.21
    Net Profit 1.87
    Net Profit Margin (%) 6.30
    Earnings Per Share (EPS) 0.89
    EBITDA 2.40
    Effective Tax Rate (%) -9.30
    Particulars SEP 2025 (Values in Cr)
    Revenue 25.63
    Operating Expense 29.22
    Net Profit 0.10
    Net Profit Margin (%) 0.39
    Earnings Per Share (EPS) 0.05
    EBITDA 0.82
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 19.11
    Operating Expense 19.29
    Net Profit 11.78
    Net Profit Margin (%) 61.64
    Earnings Per Share (EPS) 5.60
    EBITDA 12.38
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 39.11
    Operating Expense 40.09
    Net Profit -1.95
    Net Profit Margin (%) -4.98
    Earnings Per Share (EPS) -0.86
    EBITDA 2.88
    Effective Tax Rate (%) 186.66
    Particulars MAR 2026 (Values in Cr)
    Revenue 105.81
    Operating Expense 104.89
    Net Profit 14.95
    Net Profit Margin (%) 14.12
    Earnings Per Share (EPS) 7.11
    EBITDA 19.02
    Effective Tax Rate (%) 10.15
    Particulars MAR 2025 (Values in Cr)
    Revenue 111.64
    Operating Expense 109.92
    Net Profit 19.68
    Net Profit Margin (%) 17.62
    Earnings Per Share (EPS) 9.42
    EBITDA 28.31
    Effective Tax Rate (%) 23.83
    Particulars MAR 2024 (Values in Cr)
    Revenue 108.74
    Operating Expense 102.94
    Net Profit 16.78
    Net Profit Margin (%) 15.43
    Earnings Per Share (EPS) 8.01
    EBITDA 23.01
    Effective Tax Rate (%) 18.86
    Particulars MAR 2023 (Values in Cr)
    Revenue 92.44
    Operating Expense 86.42
    Net Profit 12.63
    Net Profit Margin (%) 13.66
    Earnings Per Share (EPS) 5.90
    EBITDA 17.47
    Effective Tax Rate (%) 20.77
    Particulars MAR 2022 (Values in Cr)
    Revenue 112.27
    Operating Expense 103.47
    Net Profit 14.13
    Net Profit Margin (%) 12.58
    Earnings Per Share (EPS) 6.71
    EBITDA 21.47
    Effective Tax Rate (%) 27.83
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 81.48
    ROE % 12.06
    ROCE % 15.76
    Total Debt to Total Equity 0.02
    EBITDA Margin 24.99
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 72.20
    ROE % 11.71
    ROCE % 14.32
    Total Debt to Total Equity 0.03
    EBITDA Margin 21.15
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 63.96
    ROE % 9.82
    ROCE % 12.18
    Total Debt to Total Equity 0.03
    EBITDA Margin 18.76
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 57.86
    ROE % 6.73
    ROCE % 9.30
    Total Debt to Total Equity 0.03
    EBITDA Margin 11.23
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 51.16
    ROE % 4.99
    ROCE % 7.44
    Total Debt to Total Equity 0.00
    EBITDA Margin 9.22
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 86.41
    ROE % 11.45
    ROCE % 14.96
    Total Debt to Total Equity 0.02
    EBITDA Margin 25.18
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 76.98
    ROE % 10.93
    ROCE % 13.38
    Total Debt to Total Equity 0.03
    EBITDA Margin 21.17
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 68.97
    ROE % 9.12
    ROCE % 11.33
    Total Debt to Total Equity 0.03
    EBITDA Margin 18.80
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 62.56
    ROE % 6.22
    ROCE % 8.60
    Total Debt to Total Equity 0.02
    EBITDA Margin 11.25
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 55.85
    ROE % 4.53
    ROCE % 6.77
    Total Debt to Total Equity 0.00
    EBITDA Margin 9.19
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.22
    Total Assets 222.62
    Total Liabilities 222.62
    Total Equity 171.43
    Share Outstanding 2
    Price to Book Ratio 1.20
    Return on Assets (%) 8.76
    Return on Capital (%) 11.37
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.71
    Total Assets 182.37
    Total Liabilities 182.37
    Total Equity 151.90
    Share Outstanding 2
    Price to Book Ratio 1.08
    Return on Assets (%) 9.19
    Return on Capital (%) 10.68
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 8.81
    Total Assets 167.26
    Total Liabilities 167.26
    Total Equity 134.57
    Share Outstanding 2
    Price to Book Ratio 0.78
    Return on Assets (%) 7.52
    Return on Capital (%) 9.19
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.57
    Total Assets 155.23
    Total Liabilities 155.23
    Total Equity 121.73
    Share Outstanding 2
    Price to Book Ratio 1.11
    Return on Assets (%) 9.07
    Return on Capital (%) 11.05
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 10.51
    Total Assets 140.36
    Total Liabilities 140.36
    Total Equity 107.64
    Share Outstanding 2
    Price to Book Ratio 0.65
    Return on Assets (%) 5.16
    Return on Capital (%) 6.72
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.68
    Total Assets 232.98
    Total Liabilities 232.98
    Total Equity 181.80
    Share Outstanding 2
    Price to Book Ratio 1.20
    Return on Assets (%) 8.44
    Return on Capital (%) 10.82
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.25
    Total Assets 192.42
    Total Liabilities 192.42
    Total Equity 161.97
    Share Outstanding 2
    Price to Book Ratio 1.08
    Return on Assets (%) 8.71
    Return on Capital (%) 10.03
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 8.74
    Total Assets 178.08
    Total Liabilities 178.08
    Total Equity 145.11
    Share Outstanding 2
    Price to Book Ratio 0.78
    Return on Assets (%) 7.08
    Return on Capital (%) 8.55
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.31
    Total Assets 165.13
    Total Liabilities 165.13
    Total Equity 131.63
    Share Outstanding 2
    Price to Book Ratio 1.11
    Return on Assets (%) 8.55
    Return on Capital (%) 10.27
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 10.23
    Total Assets 150.23
    Total Liabilities 150.23
    Total Equity 117.52
    Share Outstanding 2
    Price to Book Ratio 0.65
    Return on Assets (%) 4.83
    Return on Capital (%) 6.17
    Particulars MAR 2025 (Values in Cr)
    Net Income 25.81
    Cash from Operations 22.38
    Cash from Investing -12.36
    Cash from Financing -5.44
    Net change in Cash 0.51
    Free Cash Flow 33.76
    Particulars MAR 2024 (Values in Cr)
    Net Income 20.76
    Cash from Operations 7.28
    Cash from Investing -13.33
    Cash from Financing 2.58
    Net change in Cash -7.10
    Free Cash Flow 13.67
    Particulars MAR 2023 (Values in Cr)
    Net Income 15.68
    Cash from Operations 12.49
    Cash from Investing 2.12
    Cash from Financing -3.79
    Net change in Cash 7.23
    Free Cash Flow 13.62
    Particulars MAR 2022 (Values in Cr)
    Net Income 19.56
    Cash from Operations 13.05
    Cash from Investing -15.60
    Cash from Financing 5.44
    Net change in Cash -0.22
    Free Cash Flow 15.24
    Particulars MAR 2021 (Values in Cr)
    Net Income 10.79
    Cash from Operations 1.15
    Cash from Investing 5.86
    Cash from Financing 0.19
    Net change in Cash 4.34
    Free Cash Flow 4.37
    Particulars MAR 2025 (Values in Cr)
    Net Income 25.99
    Cash from Operations 22.46
    Cash from Investing -12.49
    Cash from Financing -5.47
    Net change in Cash 0.42
    Free Cash Flow 33.84
    Particulars MAR 2024 (Values in Cr)
    Net Income 20.75
    Cash from Operations 7.33
    Cash from Investing -13.44
    Cash from Financing 2.26
    Net change in Cash -7.48
    Free Cash Flow 13.71
    Particulars MAR 2023 (Values in Cr)
    Net Income 15.72
    Cash from Operations 13.79
    Cash from Investing 1.16
    Cash from Financing -3.47
    Net change in Cash 7.88
    Free Cash Flow 14.92
    Particulars MAR 2022 (Values in Cr)
    Net Income 19.57
    Cash from Operations 5.77
    Cash from Investing -15.60
    Cash from Financing 5.41
    Net change in Cash -7.99
    Free Cash Flow 7.96
    Particulars MAR 2021 (Values in Cr)
    Net Income 10.79
    Cash from Operations 1.39
    Cash from Investing 5.81
    Cash from Financing -0.02
    Net change in Cash 4.32
    Free Cash Flow 4.61
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 14.47 1.68 267.22 23.12 38.85
    BLISS GVS PHARMA LTD. 467.40 37.63 4.16 4965.84 118.35 552.90
    CIPLA LTD 1472.95 33.25 3.45 118991.58 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 501.25 23.44 3.62 1475.23 256.40 507.20
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 24.38 4.49 267.22 23.12 38.85
    AMRUTAJAN HEALTH LTD 515.00 23.08 4.02 1488.90 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8103.65 105.90 23.21 20259.13 7630.00 9850.00
    BLISS GVS PHARMA LTD. 467.40 50.58 4.29 4965.84 118.35 552.90

    ALPA LABORATORIES LTD shareholding pattern

    Holding
    42.38%
    57.18%
    0.35%
    0.06%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    ALPA LABORATORIES LTD Technicals Summary

    66.66 -0.26 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 67.10
    • 26 Days 68.00
    • 10 Days 67.40
    • 50 Days 68.10
    • 12 Days 67.50
    • 100 Days 68.90
    • 20 Days 67.80
    • 200 Days 73.90
    67.69 PIVOT
    First Support 66.40 First Resistance 68.76 Second Support 65.33 Second Resistance 70.05 Third Support 64.04 Third Resistance 71.12
    RSI 43.71 ADX 25.99 MACD -0.46 Williams % R -86.75 Commodity Channel Index (CCI) -73.54
    Date 2026-07-31 Week 5336.00 Same Day 8198.00 Month 7881.00
    1 Year 1.05 3 Year 1.03
    Over 1 Month
    -1.05% down
    Over 1 Year
    -33.82% down
    Over 3 Months
    0.99% down
    Over 3 Years
    -1.62% down
    Over 6 Months
    -1.83% down
    Over 5 Years
    6.25% down

    ALPA LABORATORIES LTD Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Alpa Laboratories Ltd?

    Answer Field

    Alpa Laboratories Ltd share price is for NSE ₹ 67.22 & for BSE ₹ 66.66 as on Aug 03 2026 03:28 PM.

    What is the Market Cap of Alpa Laboratories Ltd Share?

    Answer Field

    The market cap of Alpa Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 03 2026 03:28 PM.

    What is the 52 Week High and Low of Alpa Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Alpa Laboratories Ltd for NSE is ₹ 103.83 and ₹ 46.10 and for BSE is ₹ 102.95 and ₹ 46.00.

    What is 1 year return for Alpa Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been -33.82%.

    What is the P/E Ratio of Alpa Laboratories Ltd Share?

    Answer Field

    As on Aug 03 2026 03:28 PM the price-to-earnings (PE) ratio for Alpa Laboratories Ltd share is 9.29.

    What is the PB ratio of Alpa Laboratories Ltd Share?

    Answer Field

    As on Aug 03 2026 03:28 PM, the price-to-book (PB) ratio for Alpa Laboratories Ltd share is 93.42.

    How to Buy Alpa Laboratories Ltd Share?

    Answer Field

    You can trade in Alpa Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Alpa Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Alpa Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Alpa Laboratories Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |